Selective, genetically induced increase in synaptic vesicle priming
Science Advances · 10.04.2026 · 12 (15)
DOI: 10.1126/sciadv.aee6848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 10.04.2026. Verfasst von Mohammad Aldahabi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular Neurophysiology, HUN-REN Institute of Experimental Medicine, Budapest 1083, Hungary. Hauptthemen laut MEDLINE: Synaptic Vesicles, Nerve Tissue Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: H2020 European Research Council, German Research Foundation, Target ALS Foundation.
Abstract (Originalsprache)
Synaptic vesicle (SV) release probability ( Pv ) is determined by two probabilistic factors: the probability of release sites being occupied by fusion-competent, well-primed SVs and their fusion probability ( P fusion ). While recent studies emphasize SV priming as a key mechanism underlying functional synaptic diversity, disentangling priming from fusion is notoriously challenging. Here we developed a mouse genetic approach for inducible and selective increase of SV priming. A histidine-to-lysine mutation at position 567 of Munc13-1 increases its function. Combining this mutation with a Cre-dependent removal of the wild-type Munc13-1 allele enables cell type–selective enhancement of Munc13-1 function. This manipulation increased excitatory postsynaptic current amplitude at hippocampal synapses exclusively through elevating Pv without affecting release site number or quantal size. A sequential, two-step priming model predicts that the enhanced Pv results from an elevated proportion of well-primed SVs, without altering P fusion . Last, we provide unequivocal evidence that the postsynaptic target cell type–dependent variability in presynaptic glutamate release is mainly the consequence of variability in SV priming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular Neurophysiology, HUN-REN Institute of Experimental Medicine, Budapest 1083, Hungary.
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
- Department of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany.
ORCID-Profile: Mohammad Aldahabi, Flora Balint, Andrea Lorincz, Noa Lipstein, Nils Brose, Zoltan Nusser
Förderung
- H2020 European Research Council
- German Research Foundation
- Target ALS Foundation
- National Reseach and Innovaion Office
- National Brain Research Program (NAP 3.0) of the Hungarian Academy of Sciences
- German Research Foundation,
Zitieren
APA
Aldahabi, M., Balint, F., Lorincz, A., Lipstein, N., Brose, N., & Nusser, Z. (2026). Selective, genetically induced increase in synaptic vesicle priming. Science Advances, 12(15). https://doi.org/10.1126/sciadv.aee6848
Vancouver
Aldahabi M, Balint F, Lorincz A, Lipstein N, Brose N, Nusser Z. Selective, genetically induced increase in synaptic vesicle priming. Science Advances. 2026;12(15). doi:10.1126/sciadv.aee6848
BibTeX
@article{Aldahabi2026,
author = {Aldahabi, Mohammad and Balint, Flora and Lorincz, Andrea and Lipstein, Noa and Brose, Nils and Nusser, Zoltan},
title = {Selective, genetically induced increase in synaptic vesicle priming},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {15},
doi = {10.1126/sciadv.aee6848}
}
EUVIMED